Jazz Pharmaceuticals plc 4

4 · Jazz Pharmaceuticals plc · Filed Mar 12, 2014

Form 4

Period: 2014-03-10

SVP of Research & Dev and CMO

Transactions

Exercise/Conversion
Ordinary Shares
2014-03-10$46.83/sh+1,281$59,989→ 49,384 total
Exercise/Conversion
Ordinary Shares
2014-03-10$59.13/sh+1,719$101,644→ 51,103 total
Exercise/Conversion
Nonstatutory Stock Option (right to buy)
2014-03-10−1,281→ 36,421 total
Exercise: $46.83Exp: 2022-08-08→ Ordinary Shares (1,281 underlying)
Sale
Ordinary Shares
2014-03-10$152.99/sh−3,000$458,970→ 48,103 total
Exercise/Conversion
Nonstatutory Stock Option (right to buy)
2014-03-10−1,719→ 21,718 total
Exercise: $59.13Exp: 2023-03-04→ Ordinary Shares (1,719 underlying)

Footnotes (3)

[F1]The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
[F2]Following the reported transaction, the remaining ordinary shares subject to this option will vest with respect to 26,889 shares in twenty-one equal monthly installments from April 9, 2014 to December 9, 2015 and with respect to 9,532 shares in eight equal monthly installments from January 9, 2016 to August 9, 2016.
[F3]Following the reported transaction, the remaining ordinary shares subject to this option are vested with respect to 4,531 shares and will vest with respect to 4,687 shares in nine equal monthly installments from April 5, 2014 to December 5, 2014 and with respect to 12,500 shares in twenty-four equal monthly installments from January 5, 2015 to December 5, 2016.

Documents

1 file